Evidence map›Paper›PMID 35342812›Full record

ArticleEuropean stroke journal2021

A case series of cerebral venous thrombosis as the first manifestation of homocystinuria.

Antonio Ochoa-Ferraro, Subadra Wanninayake, Charlotte Dawson, Adam Gerrard, Mary Anne Preece, Tarekegn Geberhiwot

Open access · hybridAbstract read
In one paragraph

Article in European stroke journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Antonio Ochoa-FerraroDepartment of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Subadra WanninayakeDepartment of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Charlotte DawsonDepartment of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Adam GerrardDepartment of Newborn Screening and Biochemical Genetics, BWC NHSFT, Birmingham, UK.
Mary Anne PreeceDepartment of Newborn Screening and Biochemical Genetics, BWC NHSFT, Birmingham, UK.
Tarekegn GeberhiwotDepartment of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0002-3629-2338
Queen Elizabeth Hospital Birmingham · GBBiochemical Society · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cerebral venous thrombosis (CVT) is an important cause of stroke particularly in younger patients and potentially fatal if diagnosis is delayed. The presentation of symptoms is highly variable and consequently the diagnosis and underlying cause is often delayed or overlooked. Homocystinuria, a rare autosomal recessive disorder is an identified risk factor for CVT. Purpose: A timely diagnosis and treatment of the underlying cause of CVT could result in improved outcome and prevent further events. This case series describes the clinical course of six adults presented with unprovoked CVT, in whom the diagnosis of underlying homocystinuria was delayed with adverse consequences. We aim to highlight the importance of recognising homocystinuria as an underlying cause of CVT and offer a practical approach to the diagnosis and management. Methods: This is a retrospective case series of a cohort of 30 consecutive patients seen in a UK tertiary referral centre. Result: Six out of 30 patients presented with CVT prior to homocystinuria diagnosis. The mean and range of age at the time of the first CVT episode was 22.6 (range 11-31) years. The mean ±SD age at diagnosis of homocystinuria as the underlying cause was 26 ± 4.2 years. The time between first CVT and diagnosis of homocystinuria ranged from 1.6 to 11 years resulting in a delay to introduction of effective treatment and, in some cases, a further large vessels thrombotic event. Conclusion: Physician awareness of homocystinuria as an underlying cause for an unprovoked CVT will facilitate timely introduction of effective treatment to prevent a further event.

Indexed as

case seriescerebral venous thrombosishomocystinurialens dislocationpulmonary embolismSagittal sinus thrombosis

Identifiers

PMID35342812
PMCPMC8948514
OpenAlexW3214546660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.